Novel approaches to pediatric vaccine delivery
- PMID: 16480788
- DOI: 10.1016/j.addr.2005.12.002
Novel approaches to pediatric vaccine delivery
Abstract
Although currently available vaccines represent an outstanding success story in modern medicine and have had a dramatic effect on morbidity and mortality worldwide, it is clear that improvements in vaccine delivery are required. Vaccine delivery improvements may include the addition of novel injectable adjuvants, or the use of novel routes of delivery, including mucosal immunization. Mucosal delivery may be required to provide protection against pathogens that infect at mucosal sites, including sexually transmitted diseases. Alternatively, novel approaches to delivery, including mucosal administration, may be used to improve compliance for existing vaccines. Of particular interest for safer mass immunization are needle-free delivery devices, which would avoid problems due to needle re-use in many parts of the world, or needle-stick injuries.
Similar articles
-
Novel approaches to vaccine delivery.Pharm Res. 2004 Sep;21(9):1519-30. doi: 10.1023/b:pham.0000041443.17935.33. Pharm Res. 2004. PMID: 15497674 Free PMC article. Review.
-
Mucosal delivery of vaccine antigens and its advantages in pediatrics.Adv Drug Deliv Rev. 2006 Apr 20;58(1):52-67. doi: 10.1016/j.addr.2006.01.002. Epub 2006 Mar 3. Adv Drug Deliv Rev. 2006. PMID: 16516335 Review.
-
Needle-free vaccine delivery.Adv Drug Deliv Rev. 2006 Apr 20;58(1):68-89. doi: 10.1016/j.addr.2005.12.003. Epub 2006 Mar 24. Adv Drug Deliv Rev. 2006. PMID: 16564111 Review.
-
Advances in transcutaneous vaccine delivery: do all ways lead to Rome?J Control Release. 2010 Dec 20;148(3):266-82. doi: 10.1016/j.jconrel.2010.09.018. Epub 2010 Sep 24. J Control Release. 2010. PMID: 20869998 Review.
-
Bioadhesive delivery systems for mucosal vaccine delivery.J Drug Target. 2010 Dec;18(10):752-70. doi: 10.3109/1061186X.2010.529143. Epub 2010 Nov 2. J Drug Target. 2010. PMID: 21039314 Review.
Cited by
-
Active self-healing encapsulation of vaccine antigens in PLGA microspheres.J Control Release. 2013 Jan 10;165(1):62-74. doi: 10.1016/j.jconrel.2012.10.012. Epub 2012 Oct 24. J Control Release. 2013. PMID: 23103983 Free PMC article.
-
Solid-in-oil nanodispersions for transdermal drug delivery systems.Biotechnol J. 2016 Nov;11(11):1375-1385. doi: 10.1002/biot.201600081. Epub 2016 Aug 16. Biotechnol J. 2016. PMID: 27529824 Free PMC article. Review.
-
Mucoadhesive Multiparticulate Drug Delivery Systems: An Extensive Review of Patents.Adv Pharm Bull. 2019 Oct;9(4):521-538. doi: 10.15171/apb.2019.062. Epub 2019 Oct 24. Adv Pharm Bull. 2019. PMID: 31857957 Free PMC article. Review.
-
Development of a poly (lactic-co-glycolic acid) particle vaccine to protect against house dust mite induced allergy.AAPS J. 2014 Sep;16(5):975-85. doi: 10.1208/s12248-014-9624-5. Epub 2014 Jul 1. AAPS J. 2014. PMID: 24981892 Free PMC article.
-
The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.Acta Biomater. 2017 Mar 1;50:417-427. doi: 10.1016/j.actbio.2017.01.005. Epub 2017 Jan 4. Acta Biomater. 2017. PMID: 28063991 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical